Abdul Mannan: Here’s when Your POC INR Machine Misleads You
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
“Your POC INR device will give you a number on a DOAC patient.
Confidently. Immediately. Completely useless.
This is one of the most common ward-level anticoagulation errors I see.
Here’s when your POC INR machine misleads you:
- Triple-positive APS (LA + aCL + anti-β2GPI): may dramatically underestimate true anticoagulation intensity
- DOACs: the device still displays a result. That result means nothing.
- Haematocrit below 25% or above 55%: mechanical detection methods are especially affected
- High paraprotein: viscosity throws off clot-based chemistries
Why does this happen?
Most modern POC devices (CoaguChek XS family) don’t measure fibrin formation. They measure thrombin generation via a synthetic substrate.
That’s the source of the interference.
Successive BSH and ISTH guidance has been explicit: Triple-positive APS patients must not be monitored with POC INR devices.
I’ve just published a free interactive reference covering all 5 major UK POC INR devices, the electrochemical principle (with an animated amperometric cell diagram), a full pre/post-analytical procedure, limitations taxonomy, and the safety non-negotiables.
Free to use, no login.
What’s the trickiest POC INR case you’ve had to escalate?”
Other posts from Abdul Mannan on Hemostasis Today.
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support
-
Nov 17, 2026, 23:34Ahmed Bennis: Is Aspirin Therapy Enough for VTE Prevention After Arthroplasty?